411 related articles for article (PubMed ID: 1262785)
1. The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils.
Showell HJ; Freer RJ; Zigmond SH; Schiffmann E; Aswanikumar S; Corcoran B; Becker EL
J Exp Med; 1976 May; 143(5):1154-69. PubMed ID: 1262785
[TBL] [Abstract][Full Text] [Related]
2. Retro-all-D and retro isomers of a formyl-methionyl peptide chemoattractant: an insight into the mode of binding at the receptor on rabbit neutrophils.
Bonora GM; Toniolo C; Freer RJ; Becker EL
Biochim Biophys Acta; 1986 Dec; 884(3):545-9. PubMed ID: 3778938
[TBL] [Abstract][Full Text] [Related]
3. C3a-induced lysosomal enzyme secretion from human neutrophils: lack of inhibition by f met-leu-phe antagonists and inhibition by arachidonic acid antagonists.
Showell HJ; Glovsky MM; Ward PA
Int Arch Allergy Appl Immunol; 1982; 67(3):227-32. PubMed ID: 6800960
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of receptor-mediated chemotaxis by human spermatozoa. A novel quantitative bioassay.
Gnessi L; Ruff MR; Fraioli F; Pert CB
Exp Cell Res; 1985 Nov; 161(1):219-30. PubMed ID: 4054232
[TBL] [Abstract][Full Text] [Related]
5. The ionic basis of chemotaxis. Separate cation requirements for neutrophil orientation and locomotion in a gradient of chemotactic peptide.
Marasco WA; Becker EL; Oliver JM
Am J Pathol; 1980 Mar; 98(3):749-68. PubMed ID: 6767408
[TBL] [Abstract][Full Text] [Related]
6. Some interrelations of neutrophil chemotaxis, lysosomal enzyme secretion, and phagocytosis as revealed by synthetic peptides.
Becker EL
Am J Pathol; 1976 Nov; 85(2):385-94. PubMed ID: 793409
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of eosinophil and neutrophil chemotaxis and enzyme release.
Ogawa H; Kunkel SL; Fantone JC; Ward PA
Am J Pathol; 1981 Nov; 105(2):149-55. PubMed ID: 7294162
[TBL] [Abstract][Full Text] [Related]
8. Anti-f Met-Leu-Phe: similarities in fine specificity with the formyl peptide chemotaxis receptor of the neutrophil.
Marasco WA; Showell HJ; Freer RJ; Becker EL
J Immunol; 1982 Feb; 128(2):956-62. PubMed ID: 7033385
[TBL] [Abstract][Full Text] [Related]
9. Superoxide production induced in rabbit polymorphonuclear leukocytes by synthetic chemotactic peptides and A23187.
Becker EL; Sigman M; Oliver JM
Am J Pathol; 1979 Apr; 95(1):81-97. PubMed ID: 219701
[TBL] [Abstract][Full Text] [Related]
10. Subtle differences between human and rabbit neutrophil receptors shown by the secretagogue activity of constrained formyl peptides.
Dentino AR; Raj PA; De Nardin E
Arch Biochem Biophys; 1997 Jan; 337(2):267-74. PubMed ID: 9016822
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the rat neutrophil formyl peptide chemotaxis receptor.
Marasco WA; Fantone JC; Freer RJ; Ward PA
Am J Pathol; 1983 Jun; 111(3):273-81. PubMed ID: 6305198
[TBL] [Abstract][Full Text] [Related]
12. Conformationally constrained formyl methionyl tripeptides: structure-function study of analogs containing alpha,beta-dehydrophenylalanine and dehydroleucine.
Bharadwaj A; Singh M; Bhandary K; Becker EL; Chauhan VS
Pept Res; 1993; 6(6):298-307. PubMed ID: 8292847
[TBL] [Abstract][Full Text] [Related]
13. Use of cytochalasin B to distinguish between early and late events in neutrophil activation.
Bennett JP; Cockcroft S; Gomperts BD
Biochim Biophys Acta; 1980 Oct; 601(3):584-91. PubMed ID: 6251879
[TBL] [Abstract][Full Text] [Related]
14. The formylpeptide chemotactic receptor on rabbit peritoneal neutrophils. I. Evidence for two binding sites with different affinities.
Mackin WM; Huang CK; Becker EL
J Immunol; 1982 Oct; 129(4):1608-11. PubMed ID: 6286772
[TBL] [Abstract][Full Text] [Related]
15. Receptor blockade as a mechanism of deactivation of human neutrophils by pepstatin and formyl-Met-Leu-Phe.
Spilberg I; Mehta J; Muniain MA; Simchowitz L; Atkinson J
Inflammation; 1984 Mar; 8(1):73-86. PubMed ID: 6325345
[TBL] [Abstract][Full Text] [Related]
16. Chemiluminescence of phagocytic cells caused by N-formylmethionyl peptides.
Hatch GE; Gardner DE; Menzel DB
J Exp Med; 1978 Jan; 147(1):182-95. PubMed ID: 627835
[TBL] [Abstract][Full Text] [Related]
17. Role of peptide backbone conformation on biological activity of chemotactic peptides.
Dentino AR; Raj PA; Bhandary KK; Wilson ME; Levine MJ
J Biol Chem; 1991 Oct; 266(28):18460-8. PubMed ID: 1917969
[TBL] [Abstract][Full Text] [Related]
18. Activation of superoxide formation and lysozyme release in human neutrophils by the synthetic lipopeptide Pam3Cys-Ser-(Lys)4. Involvement of guanine-nucleotide-binding proteins and synergism with chemotactic peptides.
Seifert R; Schultz G; Richter-Freund M; Metzger J; Wiesmüller KH; Jung G; Bessler WG; Hauschildt S
Biochem J; 1990 May; 267(3):795-802. PubMed ID: 2160237
[TBL] [Abstract][Full Text] [Related]
19. Chemoattractant receptor functions in human polymorphonuclear leukocytes are divergently altered by membrane fluidizers.
Yuli I; Tomonaga A; Synderman R
Proc Natl Acad Sci U S A; 1982 Oct; 79(19):5906-10. PubMed ID: 6310554
[TBL] [Abstract][Full Text] [Related]
20. Conformationally constrained chemotactic peptide analogs of high biological activity.
Iqbal M; Balaram P; Showell HJ; Freer RJ; Becker EL
FEBS Lett; 1984 Jan; 165(2):171-4. PubMed ID: 6692914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
